Company Filing History:
4 out of 49,791 
1 out of 97 
1 out of 882 
Years Active: 2009-2020
Title: Innovations of Dong-Eun Kim in Macular Degeneration Treatment
Introduction
Dong-Eun Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of macular degeneration. With a total of seven patents to his name, his work focuses on innovative solutions to combat this debilitating condition.
Latest Patents
Among his latest patents, Dong-Eun Kim has developed a pharmaceutical composition that contains a keratin 8 phosphorylation inhibitor aimed at preventing or treating macular degeneration. This invention is particularly noteworthy as it relates to a method for screening macular degeneration medicine. The composition is designed to inhibit the phosphorylation of keratin 8 and its reorganization around nuclei in retinal pigment epithelial cells under oxidative stress conditions. This process increases the expression of E-cadherin while reducing the expression of vimentin, making it a promising candidate for the prevention or treatment of macular degeneration. Additionally, he has worked on proteasome inhibitors, which are compounds useful for inhibiting a proteasome in a cell, along with pharmaceutical compositions and methods of use.
Career Highlights
Dong-Eun Kim has had a distinguished career, working with notable companies such as LG Electronics Inc. and Konkuk University Industrial Cooperation Corporation. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations.
Collaborations
Throughout his career, Dong-Eun Kim has collaborated with talented individuals, including Eun-Mi Kim and Yoo-Seok Cho. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Dong-Eun Kim's innovative work in the field of macular degeneration treatment showcases his dedication to improving healthcare through scientific advancements. His contributions are paving the way for new therapeutic options in the fight against this condition.